Guidelines: SPKC Clinical Guidelines, algorithms, patient pathways and quality indicators Compilation (Latvia): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 51: | Line 51: | ||
<span style="display:none">availableVariable::tumor staging|staging</span> | <span style="display:none">availableVariable::tumor staging|staging</span> | ||
<span style="display:none">availableVariable::medical procedures|treatment</span> | <span style="display:none">availableVariable::medical procedures|treatment</span> | ||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | |||
<span style="display:none">isPracticeGuideline</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | <span style="display:none">hasCancerType::C50: Breast cancer</span> | ||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | ||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | <span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | ||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
Revision as of 19:08, 10 December 2025
Go back to Latvia page
Primary purpose: Provide guidelines on how to diagnose and treat several medical conditions.
Sponsor, manager or home institution: Slimību Profilakses un Kontroles Centrs (SPKC).
Type of information: Clinical practices guidelines, algorithms and pathways containing information about the diagnosis, staging, treatment, and follow-up for a number of diseases, including several types of cancer such as cervical, skin, prostate, breast, and rectal cancer. Indicators – for assessing the quality of the treatment process and compliance with clinical guidelines, algorithms and patient pathways.
Cancer areas of interest: C50: Breast cancer, C51-C58: Female genitalia cancer, C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C60-C63: Male genitalia cancer. Click here to learn more.
Access to information: Click here to access.